Our division carries out molecular, cellular, genomic, and translational studies in cancer diagnostics, mechanisms of tumour progression, and in drug development, metabolism, and resistance.
CBG by the numbers:
- 13 principal investigators
- ~75 graduate and postdoctoral trainees, technologists and research associates
- 20,000 square feet of research space, including laboratories, PIs’ offices, common equipment rooms and student workrooms.
- $3.5 M in external funding
Our funders include: